British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m

Dec.01.2025
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.

Key Points at a Glance

 

  • Sales of Velo nicotine pouches surged from 6 million units in 2023 to 29 million units in 2024, with related revenue up 442% year-on-year;
  • PJ Carroll’s net revenue rose from €30.53 million to €33.75 million, an 11% increase;
  • The company reported gross income of €179.43 million in 2024, of which about €145.67 million consisted of excise duties and other taxes;
  • Pre-tax profit fell 8% to €5.69 million, as declining cigarette volumes were only partially offset by new products and e-cigarettes;
  • Ireland plans to ban sales of nicotine pouches to minors and to restrict retail advertising and display of such products.

 


 

2Firsts, December 1, 2025 — According to the Irish Examiner,British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd said its nicotine pouch portfolio recorded strong growth last year in the Irish market, helping lift the company’s overall revenue.

 

Citing company filings, the report said sales of the Velo nicotine pouch brand rose to 29 million units in 2024, nearly a fivefold increase from 6 million units in 2023. The company noted that revenue from Velo jumped 442% year-on-year. The brand was only launched in Ireland in June 2023, contributing just 3% of total revenue that year, but it had already captured a 45.9% market share in 2024.

 

Driven by new products, PJ Carroll & Co Ltd’s net revenue increased to €33.75 million in 2024 from €30.53 million in 2023, up around 11%. The board said in its report that the performance “was primarily powered by the strong growth of Velo and continued momentum in the vaping category, partially offsetting the decline in combustible cigarette volumes.”

 

On a gross-income basis, the company recorded €179.43 million in total revenue for 2024, which included €145.67 million in excise duties and other taxes — underscoring the heavy tax environment for tobacco and nicotine products in Ireland.

 

Despite revenue growth, PJ Carroll & Co Ltd’s pre-tax profit fell 8% year-on-year to €5.69 million. The company did not disclose detailed cost breakdowns for the decline, noting only that tax burdens and market dynamics had placed pressure on profitability.

 

The rapid rise in Velo sales comes as the Irish government moves to tighten regulations. The Cabinet has authorised Health Minister Jennifer Carroll MacNeill to draft legislation that would prohibit sales of nicotine products — including nicotine pouches — to minors. The new bill would also ban advertising for such products across all retail channels and prohibit open display in mixed retail environments.

 

According to this year’s Healthy Ireland survey, around 1% of the Irish population report using nicotine pouches, with usage rising to 3% among those aged 15 to 24 and higher prevalence among men than women.

 

In terms of staffing, PJ Carroll & Co Ltd reported employing 22 people in 2024, with total staff remuneration at €1.3 million. Directors’ remuneration totalled €204,000.

 

 

Cover image: Irish Examiner

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Bill 221 (SB 221), which seeks to regulate the retail sale of nicotine products, has passed the Senate Health and Human Services Committee with a unanimous 7–0 recommendation. The bill was significantly amended, expanding from three to nine pages and shifting its focus from vapor products alone to all nicotine products.
Regulations
Feb.22
Poland Weighs Ban on Disposable Vapes, Tightens Rules on Nicotine Pouches
Poland Weighs Ban on Disposable Vapes, Tightens Rules on Nicotine Pouches
Poland plans to amend its tobacco control legislation, proposing a ban on disposable e-cigarettes (both nicotine-containing and nicotine-free) while simultaneously tightening regulations on nicotine pouches and other novel nicotine products. Nicotine pouches may be permitted only in "tobacco flavour" variants to reduce their appeal to young people.
Mar.10 by 2FIRSTS.ai
UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10
West Virginia Governor Signs Bill Directing USD 2.9 Million From Juul Settlement to Youth Tobacco Prevention
West Virginia Governor Signs Bill Directing USD 2.9 Million From Juul Settlement to Youth Tobacco Prevention
The American Cancer Society Cancer Action Network said West Virginia Governor Patrick Morrisey has signed House Bill 5691 into law, directing USD 2.9 million from the Juul settlement to youth tobacco prevention and programs that help people quit. The bill is a supplemental appropriation measure, and the Legislature’s bill history shows it passed the House on March 11, passed the Senate on March 13 and was sent to the governor on March 18.
Mar.20 by 2FIRSTS.ai
China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Company Limited announced its audited results for the year ended December 31, 2025. Revenue was HK$14.58 billion, profit before taxation was HK$1.28 billion, and profit attributable to owners of the Company was HK$0.98 billion, with basic and diluted EPS of HK$1.42. The Board proposed a final dividend of HK$0.33 per share; together with an interim dividend of HK$0.19 per share, the full-year dividend totaled HK$0.52 per share.
Mar.06 by 2FIRSTS.ai